Search results
Moderna Stock Slips as FDA Delays RSV Vaccine Approval
Investopedia· 5 days agoModerna (MRNA) shares lost ground in intraday trading Friday as the biotech’s effort to move beyond...
Merit Financial Group LLC Lowers Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 6 days agoMerit Financial Group LLC lowered its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 19.1% in the 4th quarter, according to its most recent 13F filing with the SEC ...
Moderna Says FDA Delaying Decision on RSV Vaccine Approval
Bloomberg· 4 days agoHave a confidential tip for our reporters? US regulators’ decision on whether to approve Moderna...
8. ElevateBio
CNBC· 14 hours agoIn a banner 2023, life sciences company ElevateBio struck new biotech R&D collaborations with a former No. 1 Disruptor, Moderna, and high-flying drug...
Moderna: FDA Extends RSV Vaccine Review, But No Issues Flagged
Morningstar· 4 days agoModerna on Friday said the Food and Drug Administration won't meet its May 12 target action date for a decision on the company's proposed vaccine for respiratory syncytial ...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters· 4 days ago, opens new tab respiratory syncytial virus (RSV) vaccine due to "administrative constraints" and...
Metis Global Partners LLC Trims Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 6 days agoMetis Global Partners LLC reduced its stake in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 19.9% during the fourth quarter, according to the company in its most ...
Moderna’s mRNA Dreams Meet Reality With First Post-Covid Shot
Bloomberg· 6 days agoThe biotech’s lackluster new RSV vaccine undercuts the promise of mRNA to revolutionize health care....
Moderna says FDA delaying decision on RSV vaccine approval, shares fall
Investing.com· 5 days agoModerna says FDA delaying decision on RSV vaccine approval, shares fall
FDA delays decision date for Moderna's RSV vaccine - Boston Business Journal
The Business Journals· 4 days agoJust days before its deadline, the U.S. Food and Drug Administration says it's giving itself more...